drugset / Trial / NCT00391339

Bryophyllum vs. Nifedipine

NCT00391339 ↗

Phase 2/3 Unknown 140 enrolled Weleda AG
RandomizedParallel-groupOpen-labelTreatment

Summary

In a prospective, randomised study the efficacy and tolerability of bryophyllum p. (p.o) vs. nifedipine (p.o) will be proofed in a defined group of pregnant women with threatened preterm labour.

Timeline

Start
2006-11
Primary completion
—
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bryophyllum p. Unknown — Oral

Indications

No indication recorded.